- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Uniqure NV (QURE)
Assess today's live Uniqure NV (QURE) share price, performance and insights using our live NASDAQ: QURE stock exchange data.
Analyse the historical data and Uniqure NV share price performance charts on this page. Our technical summary section provides analysis on Uniqure NV share price buy/sell indicators using real-time data (or discuss the Uniqure NV (QURE) stock price today with other investors in the Uniqure NV NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ QURE share price (ISIN: NL0010696654) to enhance your trading decisions with our free investment tools and resources.
What Is the Uniqure NV Share Price Today?
The Uniqure NV share price today is 24.180.
What Is the Stock Symbol for Uniqure NV
The stock symbol (or 'ticker') for Uniqure NV is "QURE."
What Stock Exchange Does Uniqure NV Trade On?
Uniqure NV is listed and trades on the NASDAQ stock exchange.
Is Uniqure NV a Good Stock to Buy?
Determining whether Uniqure NV—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Uniqure NV share price performance charts on this page. Our technical summary section provides analysis on Uniqure NV share price buy/sell indicators using real-time data (or discuss the Uniqure NV (QURE) stock price today with other investors in the Uniqure NV NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ QURE share price (ISIN: NL0010696654) to enhance your trading decisions with our free investment tools and resources.
What Is the Uniqure NV Share Price Today?
The Uniqure NV share price today is 24.180.
What Is the Stock Symbol for Uniqure NV
The stock symbol (or 'ticker') for Uniqure NV is "QURE."
What Stock Exchange Does Uniqure NV Trade On?
Uniqure NV is listed and trades on the NASDAQ stock exchange.
Is Uniqure NV a Good Stock to Buy?
Determining whether Uniqure NV—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
23.740
24.870
52 wk Range
7.760
71.500
QURE is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
23.74024.870
52 wk Range
7.76071.500
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
QURE Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
55.718
Upside
+130.43%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
- Uniqure Nv receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Uniqure Nv receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Uniqure Nv receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy
Uniqure NV Company Profile
uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington’s disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial temporal lobe epilepsy; AMT-162, which is in Phase I/IIa clinical trial to treat superoxide dismutase enzyme-amyotrophic lateral sclerosis; and AMT-191, an investigational gene therapy candidate which is in phase I/IIa clinical trial for the treatment of fabry disease. It has a licensing agreement with Apic Bio to develop, manufacture, and commercialize intrathecally administered investigational gene therapy for ALS caused by mutations in SOD-1; and development and commercial supply agreement with CLS Bhering. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
Compare QURE to Peers and Sector
Metrics to compare | QURE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipQUREPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.4x | −1.5x | −0.6x | |
PEG Ratio | −0.52 | 0.01 | 0.00 | |
Price/Book | 6.6x | 4.0x | 2.6x | |
Price / LTM Sales | 95.6x | 12.7x | 3.2x | |
Upside (Analyst Target) | 126.9% | 182.8% | 41.8% | |
Fair Value Upside | Unlock | 3.1% | 5.1% | Unlock |
Analyst Ratings
10 Buy
2 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 55.718
(+130.43% Upside)
Earnings
Latest Release
Nov 10, 2025
EPS / Forecast
-1.38 / -0.91
Revenue / Forecast
3.70M / 5.31M
People Also Watch
FAQ
What Is the Uniqure NV (QURE) Share Price Today?
The live Uniqure NV share price today is 24.180
What Stock Exchange Does Uniqure NV (QURE) Trade On?
Uniqure NV is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Uniqure NV?
The stock symbol (also called a 'ticker') for Uniqure NV is "QURE."
What Is the Current Uniqure NV Market Cap?
As of today, Uniqure NV market capitalisation is 1.51B.
What Is Uniqure NV's (QURE) Earnings Per Share (TTM)?
The Uniqure NV EPS is currently -4.34 (Trailing Twelve Months).
When Is the Next Uniqure NV Earnings Date?
Uniqure NV's next earnings report will be released on 02 Mar 2026.
Is QURE a Buy or Sell From a Technical Analyst Perspective?
Based on today's Uniqure NV moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Uniqure NV Stock Split?
Uniqure NV has split 0 times. (See the QURE stock split history page for full effective split date and price information.)
How Many Employees Does Uniqure NV Have?
Uniqure NV has 209 employees.
What is the current trading status of Uniqure NV (QURE)?
As of 24 Dec 2025, Uniqure NV (QURE) is trading at a price of 24.180, with a previous close of 24.980. The stock has fluctuated within a day range of 23.740 to 24.870, while its 52-week range spans from 7.760 to 71.500.
What Is Uniqure NV (QURE) Price Target According to Analysts?
The average 12-month price target for Uniqure NV is USD55.71771438, with a high estimate of USD96.84839272 and a low estimate of USD33.52476138. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +130.43% Upside potential.
What Is the QURE Premarket Price?
QURE's last pre-market stock price is 24.770. The pre-market share volume is 4,490.000, and the stock has decreased by -0.210, or -0.840%.
What Is the QURE After Hours Price?
QURE's last after hours stock price is 23.690, the stock has decreased by -0.490, or -2.030%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.